The effect of nicorandil on arrhythmia

Investigation the effect of oral nicorandil on arrhythmia rate in patients undergoing angioplasty

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20181104041555N1

Enrollment

100

Registered

2018-12-13

Start date

2018-12-22

Completion date

Unknown

Last updated

2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Myocardial infarction. ST elevation (STEMI) and non-ST elevation (NSTEMI) myocardial infarction

Interventions

Intervention 1: Intervention group: Receiving 20 mg nicorandil orally twice a day since admission till discharge. Intervention 2: Control group: Receiving nicorandil placebo twice a day since admissi

Eligibility

Sex/Gender

All

Age

20 Years to 75 Years

Inclusion criteria

Inclusion criteria: Having a definite diagnosis of myocardial infarction

Exclusion criteria

Exclusion criteria: Cardiogenic shock Previous use of nicorandil Undergoing cardiopulmonary resuscitation

Design outcomes

Primary

Measure	Time frame
Arrhythmia. Timepoint: After angiography for 48 hours. Method of measurement: By evaluating the electrocardiogram by cardiologist.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHesam Mullazehi

Zahedan University of Medical Sciences

h.mullazehi.med@zaums.ac.ir+98 54 3329 5715

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026